Blue Cross files reply backing dismissal of US claims over spinal fusions
MLex Summary: Blue Cross Blue Shield filed a reply supporting its motion to dismiss TranS1’s US claims accusing it of conspiring to keep TranS1 out of the market by refusing to...To view the full article, register now.
Already a subscriber? Click here to view full article